The N.C.I.N. organised this conference, which was held at Birmingham’s N.E.C,.
This was a brave attempt at involving patients and professionals equally. However, it did prove that medical professionals may pay lip service to ‘involving’ patients, but often, in reality, have difficulty in addressing this issue.
Paying lip service
The aim of the conference was laudable ; patients were to be treated as equals. In fact, we were even given free accommodation and free travel if we were a genuine patient. However, the professionals were still being condescending, and not quite up to sharing information equally. But patients are used to this, and we all got useful information from the event. Out of around 500 delegates, probably one fifth were patients, so we weren’t overwhelmed ! Speakers were generally excellent, and as other delegates confirmed, they didn’t ‘talk down’ to us. They spoke enthusiastically, and didn’t use too much jargon !What’s happening in Europe ?
Proving that the N.C.I.N. are not only concerned about the EU’s better cancer outcomes, but were keen to do something about it – a major session saw Dr Jane Hanson, Lead Advisor for Cancer, Welsh Government & Head of Cancer National Specialist Advisory Group Core Team, introduce a session entitled ‘Towards a European cancer information system; the EUROCOURSE project and beyond”. This was followed by presentations from Harry Comber, Director, Irish National Cancer Registry on ‘ Cancer survival in Europe’ : “first results from the EUROCARE-5 study. Dr Roberta De Angelis, Senior Researcher, National Centre of Epidemiology, Italian National Institute of Health talked about ‘The International Cancer Benchmarking Partnership (ICBP), and Dr Martine Bomb, Programme Manager, Cancer Research UK gave the UK perspective. These were all excellent speakers, but one couldn’t help wishing that more time had been allotted, to enable the very interested audience to have an opportunity to ask questions and get a good dialogue going. A packed room was filled with delegates eager to ask questions – but sadly not enough time to get them out. One piece of information that was flashed onto the screens was a slide showing where research was being carried out in Europe : 10 work packages have been produced, covering :- WP1 Exchange of knowledge about national programmes
- WP2 Ethical conduct of research
- WP3 Tools for improving the quality, coverage and use of cancer registration data in Europe
- WP4 The development, harmonization, analysis and exchange of European cancer registry data
- WP5 Interface of cancer registries with cancer screening programmes
- WP6 Interface of cancer registries with clinical care
- WP7 Interface of cancer registries with biobanks
- WP8 Dissemination of findings and training
- WP9 European cancer control summit
- WP10 Coordination of EUROCOURSE activities